ODDO BHF ASSET MANAGEMENT SAS
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1686970
PARIS, I0
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,042,306
+$509,479 QoQ
Shares Held
10,151
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#472
of 1,730 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ODDO BHF ASSET MANAGEMENT SAS holds $77,360,522 across 7 Biotechnology names. VRTX ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
128,657 | $34,315,395 | |
| 2 | ARGX |
Argenx SE
|
25,009 | $23,202,599 | |
| 3 | ABVX |
Abivax S.A.
|
81,496 | $10,860,156 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
10,151 | $5,042,306 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,074 | $3,333,606 | |
| 6 | RNA |
Atrium Therapeutics, Inc.
|
45,090 | $606,460 | |
| 7 | NUVL |
Nuvalent, Inc.
|
227,386 | $0 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,042,306 | 10,151 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,532,827 | 10,151 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $21,141,536 | 46,633 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,032,995 | 33,278 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,515,137 | 12,388 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,095,039 | 16,697 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $7,157,187 | 17,773 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,912,406 | 17,013 | Shares | Sole | 2024-12-03 | |
| No filing history on record for this holder in this stock. | ||||||